nodes	percent_of_prediction	percent_of_DWPC	metapath
Lofexidine—Clonidine—SLC22A1—hematologic cancer	0.065	0.775	CrCbGaD
Lofexidine—Clonidine—ABCB1—hematologic cancer	0.0189	0.225	CrCbGaD
Lofexidine—ADRA2A—Signaling by GPCR—CSF2—hematologic cancer	0.000488	0.000533	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—IL2RA—hematologic cancer	0.000485	0.000529	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—XIAP—hematologic cancer	0.000481	0.000525	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CBL—hematologic cancer	0.000477	0.000521	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	0.000473	0.000516	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL3—hematologic cancer	0.000472	0.000515	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PRKCG—hematologic cancer	0.000471	0.000514	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—JAK1—hematologic cancer	0.000471	0.000514	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SMARCA4—hematologic cancer	0.000469	0.000512	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SH2B3—hematologic cancer	0.000469	0.000512	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CG—hematologic cancer	0.000466	0.000509	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GZMB—hematologic cancer	0.000466	0.000509	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PTPN1—hematologic cancer	0.000464	0.000507	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PTPN11—hematologic cancer	0.000458	0.0005	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—RASGRP1—hematologic cancer	0.000457	0.000498	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CTNNA1—hematologic cancer	0.000455	0.000497	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HSP90AA1—hematologic cancer	0.000455	0.000497	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SYK—hematologic cancer	0.000455	0.000497	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CD44—hematologic cancer	0.000455	0.000497	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NQO1—hematologic cancer	0.000455	0.000497	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EIF4EBP1—hematologic cancer	0.000453	0.000494	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HSPB1—hematologic cancer	0.000453	0.000494	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCL3—hematologic cancer	0.000453	0.000494	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000451	0.000493	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—IL2—hematologic cancer	0.000449	0.000491	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTHLH—hematologic cancer	0.000447	0.000488	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SDC1—hematologic cancer	0.000447	0.000488	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CREB1—hematologic cancer	0.000444	0.000485	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL2RA—hematologic cancer	0.00044	0.00048	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—STAT1—hematologic cancer	0.000439	0.000479	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTGER4—hematologic cancer	0.000436	0.000476	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CCL2—hematologic cancer	0.000434	0.000474	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LCK—hematologic cancer	0.000433	0.000473	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL6R—hematologic cancer	0.000433	0.000473	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYCS—hematologic cancer	0.000431	0.00047	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HSP90AA1—hematologic cancer	0.000428	0.000467	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000426	0.000465	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—H3F3A—hematologic cancer	0.000425	0.000464	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—JAK2—hematologic cancer	0.000414	0.000452	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PRKCZ—hematologic cancer	0.000413	0.000451	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—MAP2K1—hematologic cancer	0.000413	0.000451	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GRB2—hematologic cancer	0.000411	0.000448	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CD—hematologic cancer	0.00041	0.000448	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PDGFA—hematologic cancer	0.00041	0.000447	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KITLG—hematologic cancer	0.000404	0.000441	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CG—hematologic cancer	0.000404	0.000441	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—EP300—hematologic cancer	0.000403	0.00044	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PARP1—hematologic cancer	0.000399	0.000435	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—STAT5A—hematologic cancer	0.000395	0.000431	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000394	0.00043	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FBXW7—hematologic cancer	0.000392	0.000428	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—SRC—hematologic cancer	0.000392	0.000428	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CDKN2B—hematologic cancer	0.000391	0.000427	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3R1—hematologic cancer	0.000387	0.000423	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HDAC2—hematologic cancer	0.000385	0.00042	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCR4—hematologic cancer	0.000385	0.00042	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—VEGFA—hematologic cancer	0.000382	0.000417	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GSTP1—hematologic cancer	0.00038	0.000414	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CD86—hematologic cancer	0.000378	0.000413	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—NRAS—hematologic cancer	0.000377	0.000412	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—JAK2—hematologic cancer	0.000376	0.000411	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CBL—hematologic cancer	0.000375	0.000409	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HES1—hematologic cancer	0.000373	0.000407	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL3—hematologic cancer	0.000371	0.000405	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NCOR1—hematologic cancer	0.000371	0.000405	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGF1—hematologic cancer	0.000367	0.0004	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CSF2—hematologic cancer	0.000367	0.0004	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CG—hematologic cancer	0.000367	0.0004	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTPN1—hematologic cancer	0.000365	0.000398	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FOXO1—hematologic cancer	0.000362	0.000395	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—IL2—hematologic cancer	0.000361	0.000395	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—MAPK3—hematologic cancer	0.000361	0.000394	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PDGFRB—hematologic cancer	0.000361	0.000394	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PTPN11—hematologic cancer	0.00036	0.000393	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ABCB1—hematologic cancer	0.000359	0.000392	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—RASGRP1—hematologic cancer	0.000359	0.000392	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HSP90AA1—hematologic cancer	0.000358	0.00039	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SYK—hematologic cancer	0.000358	0.00039	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CB—hematologic cancer	0.000357	0.00039	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PDGFRA—hematologic cancer	0.000355	0.000388	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000355	0.000387	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—JAK1—hematologic cancer	0.000354	0.000387	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PRKCG—hematologic cancer	0.000354	0.000387	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TGFB1—hematologic cancer	0.000351	0.000383	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CREB1—hematologic cancer	0.000349	0.000381	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NCOR1—hematologic cancer	0.000349	0.000381	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GSTM1—hematologic cancer	0.000349	0.000381	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—STAT1—hematologic cancer	0.000345	0.000377	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCL2—hematologic cancer	0.000341	0.000373	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL6R—hematologic cancer	0.00034	0.000372	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000335	0.000366	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL2RA—hematologic cancer	0.000331	0.000361	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL2—hematologic cancer	0.000328	0.000358	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TERT—hematologic cancer	0.000327	0.000357	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—JAK2—hematologic cancer	0.000326	0.000355	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—KRAS—hematologic cancer	0.000325	0.000354	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—MAP2K1—hematologic cancer	0.000324	0.000354	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GRB2—hematologic cancer	0.000323	0.000352	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CD—hematologic cancer	0.000322	0.000352	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PDGFA—hematologic cancer	0.000322	0.000351	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PDGFB—hematologic cancer	0.000319	0.000348	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KITLG—hematologic cancer	0.000317	0.000346	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TSC2—hematologic cancer	0.000312	0.000341	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—STAT5A—hematologic cancer	0.00031	0.000339	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000309	0.000338	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—MTHFR—hematologic cancer	0.000308	0.000336	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CDKN2B—hematologic cancer	0.000307	0.000336	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3R1—hematologic cancer	0.000304	0.000332	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGFR3—hematologic cancer	0.0003	0.000328	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PIK3CA—hematologic cancer	0.000298	0.000326	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CD86—hematologic cancer	0.000297	0.000325	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MAPK14—hematologic cancer	0.000297	0.000324	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—JAK2—hematologic cancer	0.000296	0.000323	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HES1—hematologic cancer	0.000293	0.00032	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NCOR1—hematologic cancer	0.000292	0.000318	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ESR1—hematologic cancer	0.000291	0.000318	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TP53—hematologic cancer	0.000289	0.000315	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGF1—hematologic cancer	0.000288	0.000315	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CSF2—hematologic cancer	0.000288	0.000315	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FN1—hematologic cancer	0.000288	0.000314	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—BAD—hematologic cancer	0.000284	0.000311	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NFKBIA—hematologic cancer	0.000284	0.000311	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FOXO1—hematologic cancer	0.000284	0.00031	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—IL2—hematologic cancer	0.000284	0.00031	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PDGFRB—hematologic cancer	0.000284	0.00031	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NOTCH1—hematologic cancer	0.000282	0.000308	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CB—hematologic cancer	0.000281	0.000307	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PDGFRA—hematologic cancer	0.000279	0.000305	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PRKCG—hematologic cancer	0.000278	0.000304	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—JAK1—hematologic cancer	0.000278	0.000304	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—HRAS—hematologic cancer	0.000276	0.000301	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CD80—hematologic cancer	0.000276	0.000301	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CG—hematologic cancer	0.000276	0.000301	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KIT—hematologic cancer	0.000276	0.000301	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—NRAS—hematologic cancer	0.000276	0.000301	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PTPN11—hematologic cancer	0.000271	0.000295	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—MAPK3—hematologic cancer	0.000264	0.000288	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CREB1—hematologic cancer	0.000262	0.000286	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL2RA—hematologic cancer	0.00026	0.000284	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—BRAF—hematologic cancer	0.000259	0.000283	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CG—hematologic cancer	0.000259	0.000283	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL2—hematologic cancer	0.000258	0.000282	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TERT—hematologic cancer	0.000257	0.000281	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCL2—hematologic cancer	0.000257	0.00028	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL6R—hematologic cancer	0.000256	0.000279	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CREBBP—hematologic cancer	0.000255	0.000279	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PDGFB—hematologic cancer	0.000251	0.000274	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TSC2—hematologic cancer	0.000245	0.000268	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MAP2K1—hematologic cancer	0.000244	0.000266	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—AKT1—hematologic cancer	0.000244	0.000266	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CD—hematologic cancer	0.000242	0.000264	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CREBBP—hematologic cancer	0.00024	0.000262	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	0.00024	0.000262	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—KRAS—hematologic cancer	0.000237	0.000259	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGFR3—hematologic cancer	0.000236	0.000257	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MAPK14—hematologic cancer	0.000234	0.000255	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGF2—hematologic cancer	0.000232	0.000253	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ESR1—hematologic cancer	0.000229	0.00025	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3R1—hematologic cancer	0.000229	0.00025	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CD—hematologic cancer	0.000228	0.000249	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FN1—hematologic cancer	0.000226	0.000247	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ALB—hematologic cancer	0.000225	0.000245	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—BAD—hematologic cancer	0.000224	0.000244	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NFKBIA—hematologic cancer	0.000224	0.000244	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—JAK2—hematologic cancer	0.000222	0.000243	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOTCH1—hematologic cancer	0.000221	0.000242	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CA—hematologic cancer	0.000218	0.000238	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MDM2—hematologic cancer	0.000217	0.000237	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CD80—hematologic cancer	0.000217	0.000237	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CG—hematologic cancer	0.000217	0.000236	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KIT—hematologic cancer	0.000217	0.000236	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—NRAS—hematologic cancer	0.000217	0.000236	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3R1—hematologic cancer	0.000215	0.000235	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTPN11—hematologic cancer	0.000213	0.000232	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MTOR—hematologic cancer	0.000211	0.00023	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CB—hematologic cancer	0.000211	0.00023	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—MAPK3—hematologic cancer	0.000207	0.000226	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CREB1—hematologic cancer	0.000206	0.000225	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—BRAF—hematologic cancer	0.000204	0.000222	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCL2—hematologic cancer	0.000202	0.00022	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HRAS—hematologic cancer	0.000202	0.00022	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL6R—hematologic cancer	0.000201	0.000219	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CREBBP—hematologic cancer	0.000201	0.000219	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CB—hematologic cancer	0.000198	0.000217	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	0.000198	0.000216	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	0.000196	0.000214	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CASP3—hematologic cancer	0.000194	0.000212	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL2—hematologic cancer	0.000194	0.000212	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL6—hematologic cancer	0.000193	0.000211	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MAP2K1—hematologic cancer	0.000192	0.000209	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CD—hematologic cancer	0.00019	0.000208	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCND1—hematologic cancer	0.000189	0.000206	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—JUN—hematologic cancer	0.000189	0.000206	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000189	0.000206	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—KRAS—hematologic cancer	0.000186	0.000203	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	0.000183	0.0002	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PTEN—hematologic cancer	0.000182	0.000199	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGF2—hematologic cancer	0.000182	0.000199	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3R1—hematologic cancer	0.00018	0.000196	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	0.000178	0.000195	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	0.000178	0.000194	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—JAK2—hematologic cancer	0.000175	0.000191	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EP300—hematologic cancer	0.000174	0.00019	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PTEN—hematologic cancer	0.000171	0.000187	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CA—hematologic cancer	0.000171	0.000187	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MDM2—hematologic cancer	0.000171	0.000186	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SRC—hematologic cancer	0.000169	0.000185	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MTOR—hematologic cancer	0.000166	0.000181	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CB—hematologic cancer	0.000166	0.000181	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	0.000165	0.00018	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—EP300—hematologic cancer	0.000164	0.000178	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—STAT3—hematologic cancer	0.000163	0.000178	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NRAS—hematologic cancer	0.000163	0.000178	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HRAS—hematologic cancer	0.000158	0.000173	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	0.000156	0.00017	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CDKN1B—hematologic cancer	0.000156	0.00017	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AKT1—hematologic cancer	0.000154	0.000168	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	0.000153	0.000167	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL2—hematologic cancer	0.000152	0.000166	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	0.000152	0.000166	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MYC—hematologic cancer	0.000152	0.000165	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	0.000151	0.000165	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	0.000149	0.000162	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—JUN—hematologic cancer	0.000148	0.000162	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	0.000144	0.000157	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	0.000143	0.000157	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	0.00014	0.000153	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KRAS—hematologic cancer	0.00014	0.000153	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	0.00014	0.000153	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EP300—hematologic cancer	0.000137	0.000149	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SRC—hematologic cancer	0.000133	0.000145	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	0.00013	0.000141	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	0.000129	0.00014	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	0.000128	0.00014	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	0.000128	0.00014	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TP53—hematologic cancer	0.000124	0.000136	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	0.000123	0.000134	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CA—hematologic cancer	0.000121	0.000132	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MYC—hematologic cancer	0.000119	0.00013	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HRAS—hematologic cancer	0.000119	0.00013	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	0.000119	0.00013	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL6—hematologic cancer	0.000114	0.000124	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	0.00011	0.00012	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKT1—hematologic cancer	0.000105	0.000115	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	0.000101	0.00011	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AKT1—hematologic cancer	9.88e-05	0.000108	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TP53—hematologic cancer	9.79e-05	0.000107	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	9.36e-05	0.000102	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL6—hematologic cancer	8.96e-05	9.78e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	8.26e-05	9.02e-05	CbGpPWpGaD
